US FDA rejects EUA for Covaxin

June 11, 2021

The US’ Food and Drug Administration (FDA) on Friday rejected emergency use authorisation for Bharat Biotech’s Covaxin vaccine, instead recommending that the vaccine manufacturer’s US partner apply for biologics licence application (BLA), PTI reported. BLA is a “full approval” mechanism by the FDA for drugs a | Read more|